Profiel
Eric Meldrum is currently the Chief Scientific Officer at ENYO Pharma SA and Citryll BV.
He previously held the position of Chief Scientific Officer at Calliditas Therapeutics Suisse SA.
Actieve functies van Eric Meldrum
| Bedrijven | Functie | Begin |
|---|---|---|
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Hoofd Techniek/Wetenschap/O&O | 29-08-2023 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Eric Meldrum
| Bedrijven | Functie | Einde |
|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Commercial Services |
















